|
Volumn 100, Issue 4, 2002, Pages 1220-1223
|
Genetic variability in the extracellular matrix as a determinant of cardiovascular risk: Association of type III collagen COL3A1 polymorphisms with coronary artery disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COLLAGEN FIBER;
COLLAGEN TYPE 3;
COLLAGEN TYPE 3A1;
GENE PRODUCT;
ORBOFIBAN;
UNCLASSIFIED DRUG;
ADULT;
ALLELE;
ARTICLE;
CARDIOVASCULAR RISK;
CAUCASIAN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
EXTRACELLULAR MATRIX;
GENE FREQUENCY;
GENE INTERACTION;
GENETIC CODE;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
GENOTYPE;
HEART INFARCTION;
HOSPITALIZATION;
HUMAN;
INTRON;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RISK ASSESSMENT;
TANDEM REPEAT;
THROMBOCYTE ACTIVATION;
THROMBOSIS;
UNSTABLE ANGINA PECTORIS;
|
EID: 0037103259
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood-2002-01-0283 Document Type: Article |
Times cited : (24)
|
References (21)
|